Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The multidisciplinary approach to bone metastases.

Ronald H Blum1, Danielle Novetsky, Danielle Shasha

  • 1Department of Medicine, Albert Einstein College of Medicine, New York, USA. rblum@bethisraelny.org

Oncology (Williston Park, N.Y.)
|July 9, 2003
PubMed
Summary

Early identification and integrated care programs are crucial for managing cancer patients with bone metastases. Bisphosphonates help reduce complications and improve quality of life by managing metastatic bone pain.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NCCN Guidelines® Insights: Distress Management, Version 1.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

NCCN Guidelines® Insights: Distress Management, Version 2.2023.

Journal of the National Comprehensive Cancer Network : JNCCN·2023
Same author

Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2019
Same author

Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis.

European journal of cancer (Oxford, England : 1990)·2015
Same author

Effects of denosumab on pain and analgesic use in giant cell tumor of bone: interim results from a phase II study.

Acta oncologica (Stockholm, Sweden)·2014
Same author

Impact of oncology drug shortages on patient therapy: unplanned treatment changes.

Journal of oncology practice·2013

Area of Science:

  • Oncology
  • Palliative Care
  • Bone Metastasis Management

Background:

  • Advances in cancer care prolong survival, increasing the incidence of metastatic bone disease.
  • Bone metastases lead to significant morbidity, including pain, fractures, and neurological complications.
  • Early risk identification is essential for proactive diagnosis and treatment.

Purpose of the Study:

  • To highlight the importance of early identification of patients at risk for bone metastases.
  • To advocate for a multidisciplinary approach in managing cancer with bone metastases.
  • To emphasize the role of bisphosphonates in reducing skeletal-related events and improving quality of life.

Main Methods:

  • Review of current management strategies for metastatic bone disease.

Related Experiment Videos

  • Discussion of the benefits of bisphosphonates in skeletal complication reduction.
  • Argument for integrated bone metastases programs within primary cancer care.

    • Main Results:

    • Bisphosphonates effectively reduce skeletal-related complications and metastatic bone pain.
    • Integrated care models can address the complexity of managing bone metastases.
    • Proactive management improves patient outcomes and quality of life.

    Conclusions:

    • A thematically integrated bone metastases program is recommended for optimal patient care.
    • Multidisciplinary collaboration is key to managing the complexities of bone metastases.
    • Early intervention and bisphosphonate therapy improve outcomes for cancer patients with bone disease.